Cancer image analysis software to be tested:
This article was originally published in Clinica
Executive Summary
Confirma is to begin two clinical studies to assess its ACCENT data analysis software product that works with MRI to determine the extent of disease in cancer patients. The product, which is designed to provide information about both the location and volume of cancerous tumours, will be tested in patients with either breast or prostate cancer. The ACCENT system provides information that is critical to treatment planning and for following the progress of therapy, said the Kirkland, Washington-based company.
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.